Materias dentro de su búsqueda.
Mostrando 15,841 - 15,860 Resultados de 16,624 Para Buscar '"hepatitis B"', tiempo de consulta: 3.59s Limitar resultados
  1. 15841
    “…Furthermore, we found a positive association between the frequency of students who had not been vaccinated (varicella 2.3%vs3.9%, p = 0.00) or who did not know if they were (varicella 8.2%vs22.8%, p = 0.00; Hepatitis B 11.4%vs20.5%, p = 0.02; Tdap 4.6%vs15.0%, p = 0.00) and HI (low vs high). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Medical students’ vaccine hesitancy, knowledge and attitudes: A cross-sectional study
  2. 15842
    “…T. pallidum was detected in 43 (18.6%) of these patients, Cytomegalovirus (CMV) in 32 (13.9%), Epstein–Barr virus (EBV) in 9 (3.9%), Hepatitis B virus (HBV) in 10 (4.3%), C. albicans in 7 (3%), M. tuberculosis in 3 (1.3%), Hepatitis C virus (HCV) in 2 (0.8%), and C. glabrata in 1 (0.4%) patient. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Distribution of Opportunistic Pathogens in People Living with HIV at a University Hospital in Istanbul over a One-Year Treatment Period and Its Association with CD4 T Cell Counts
  3. 15843
    “…OBJECTIVE: To explore differences of tenofovir disoproxil vs entecavir in recurrence-free survival (RFS) and OS after liver resection with curative intent in patients with hepatocellular cancer (HCC) related to hepatitis B virus (HBV). DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted at Eastern Hepatobiliary Surgery Hospital, a tertiary referral hospital in Shanghai, China, between January 4, 2015, and April 1, 2023. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Tenofovir vs Entecavir Among Patients With HBV-Related HCC After Resection
  4. 15844
    “…OBJECTIVE: Haematological and liver fibrotic markers could be appreciably utilized for effective monitoring of Chronic Hepatitis B viral (HBV) infection, thereby increasing patient’s treatment outcome. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessment of the performance of haematological and non-invasive fibrotic indices for the monitoring of chronic HBV infection: a pilot study in a Ghanaian population
  5. 15845
    por Yao, Bilian, Xu, Qi, Zhang, Xinxin, Han, Yue
    Publicado 2023
    “…Background: Constant cellular damage causes a poor prognosis of hepatitis B virus (HBV) infection. Accumulating evidence indicates the cytoprotective properties of bilirubin. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Genetic variations underlying Gilbert syndrome and HBV infection outcomes: a cross-sectional study
  6. 15846
    “…Common conditions diagnosed in this population are tuberculosis (13.58%), hepatitis B (6.13%), Kaposi sarcoma (3.07%), and esophageal candidiasis (2.45%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence and factors associated with advanced HIV disease among young people aged 15 – 24 years in a national referral hospital in Sierra Leone: A cross-sectional study
  7. 15847
    por Aslam, Samia, Yan, Peng, Butt, Adeel A
    Publicado 2023
    “…We excluded individuals with prevalent PD diagnosis (any PD diagnosis before the first HCV positive test date and the match date for corresponding controls), HIV or hepatitis B virus coinfection from both groups, and those with missing or undetectable baseline HCV RNA values among the HCV infected group. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2491. The Association of Parkinson’s Disease with Hepatitis C Virus Infection and Its Treatment
  8. 15848
    “…Eligible participants were 18+ years old with a most recent HIV-1 viral load < 200 copies/ml, without any evidence of genotypic resistance to LAI components or chronic hepatitis B. Survey recipients were asked questions on their current treatment, their awareness and interest in LAI, and were asked to rate common benefits and concerns associated with LAI. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1609. Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
  9. 15849
    “…Unique PrEP users were defined as persons with ≥1 fill of PrEP during the calendar year (CY), excluding those with a diagnosis for HIV or chronic hepatitis B prior to the first fill in CY. A new HIV diagnosis was defined as a first ever positive HIV confirmatory test or detectable HIV viral load prior to first ever antiretroviral fill in a CY. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2898. PrEP Inequity Across Geographic, Racial and Sex Groups in a Nationwide US Veteran Cohort
  10. 15850
    “…BACKGROUND: In New York City (NYC), an estimated 243,000 people live with chronic hepatitis B virus (HBV) infection and 86,000 people live with chronic hepatitis C virus (HCV) infection, representing 2.9% and 1% of the population, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2501. Trends in viral hepatitis and hepatocellular carcinoma in New York City, 2001–2018
  11. 15851
    “…BACKGROUND: Antiviral therapy has been reported to be associated with lower recurrence rate of hepatocellular carcinoma (HCC) for patients with hepatitis B virus (HBV) infection. While entecavir (ETV) and tenofovir disoproxil fumarate (TDF) were both recommended as first-line therapies for HBV patients, recent retrospective studies proposed a lower incidence rate of HCC occurrence or recurrence in those receiving TDF compared ETV. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The effect of switch therapy to tenofovir versus entecavir maintenance on recurrence of hepatocellular carcinoma after surgery (SWITE): study protocol for a randomized controlled trial
  12. 15852
    “…The control vaccine was the hepatitis B vaccine (Recombivax). Participants were enrolled into 1 of 3 dose cohorts (n = 18 per cohort) and randomized 2∶1 to receive either AMA1-C1 or Recombivax. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians
  13. 15853
    “…METHODS: A national multicenter cross-sectional study was undertaken on correlates of human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis infections in sample of prison inmates and officers from eight of ten regional central prisons in Ghana. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study
  14. 15854
    “…A child was said to be fully immunized if he or she had received all of the following vaccines: a dose of Bacille Calmette Guerin (BCG), three doses of oral polio (OPV), three doses of diphtheria, pertussis and tetanus (DPT), three doses of hepatitis B (HB) and one dose of measles by the time he or she was enrolled in the survey, i.e. between the ages of 12–23 months. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Determinants of vaccination coverage in rural Nigeria
  15. 15855
    “…Each group received 3 vaccine doses (on days 0, 28 and 56) of either 15 µg of MSP3-LSP, 30 µg of MSP3-LSP or of the Engerix B hepatitis B vaccine. Children were visited at home daily for the 6 days following each vaccination to solicit symptoms which might be related to vaccination. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children
  16. 15856
    “…There were no treatment-emergent viral infections in any subject for human immunodeficiency virus, hepatitis B or C, or parvovirus B19 during the course of the study. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Pharmacokinetic comparability of Prolastin(®)-C to Prolastin(® )in alpha(1)-antitrypsin deficiency: a randomized study
  17. 15857
    “…The commonest types of infections reported are tuberculosis, chronic diarrhoea, oral candidiasis, herpes simplex virus-2, cytomegalovirus, hepatitis B virus and hepatitis C virus. Due to the scarcity of OIs data available from this region, we had designed a study to determine the frequency of different OIs amongst HIV seropositive patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Recent pattern of Co-infection amongst HIV seropositive individuals in tertiary care hospital, kolkata
  18. 15858
    “…A multivariate logistic analysis was performed using anal HPV infection as the dependent variable versus a set of covariates: age, HIV plasma viral load, CD4+ count, hepatitis B virus (HBV) serology, hepatitis C virus (HCV) serology, syphilis serology and HHV-8 viral shedding. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men
  19. 15859
    “…METHODS: Proportional hazards models were used to investigate an association between an estimated glomerular filtration rate decrease >25% from baseline (ie, renal impairment) and demographics, antiretroviral/nonantiretroviral medications, comorbidities (hypertension, diabetes mellitus, hepatitis C virus [HCV] infection, hepatitis B virus [HBV] infection), CD4+ counts, viral load, and duration patients were monitored at the clinic (time on study). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population
  20. 15860
    “…In the STK1 elevated group of the city-dwelling people, a statistically significantly higher number of people were found to have malignancies, pre-malignancies of all types, moderate/severe type of hyperplasia of breast or prostate, or refractory anaemia, or to be at high risk for hepatitis B, compared to people with normal STK1 values (<2.0 pM). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Serological Thymidine Kinase 1 is a Biomarker for Early Detection of Tumours—A Health Screening Study on 35,365 People, Using a Sensitive Chemiluminescent Dot Blot Assay
Herramientas de búsqueda: RSS